• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 07/24/14

    • 30-Day SEC Yield1

      1.85%
    • Total Net Assets

      $324.6M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2014
  • Portfolio Composition (%)
    as of 07/24/14

    • % of Net Assets
    • Stocks

      100.19
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.19
  • Download All HoldingsAll Holdings (%)as of 07/24/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    325,874
    33,304,32310.26
    Novartis Ag
    NVS US
    350,245
    31,217,3379.62
    Pfizer Inc
    PFE US
    774,915
    23,510,9217.24
    Merck & Co Inc
    MRK US
    310,143
    18,053,4245.56
    Sanofi
    SNY US
    310,454
    16,152,9224.98
    Novo Nordisk A/S
    NVO US
    345,298
    15,700,7004.84
    Eli Lilly & Co
    LLY US
    232,121
    14,941,6294.60
    Abbott Laboratories
    ABT US
    345,109
    14,882,7174.59
    Bristol-Myers Squibb Co
    BMY US
    293,962
    14,655,5444.52
    Teva Pharmaceutical Industries Ltd
    TEVA US
    265,568
    14,446,8994.45
    Allergan Inc/United States
    AGN US
    84,596
    14,429,5404.45
    Actavis Plc
    ACT US
    65,129
    14,242,4104.39
    Glaxosmithkline Plc
    GSK US
    282,470
    14,146,0984.36
    Abbvie Inc
    ABBV US
    254,549
    13,880,0584.28
    Astrazeneca Plc
    AZN US
    185,991
    13,860,0494.27
    Shire Plc
    SHPG US
    54,787
    13,857,8244.27
    Mckesson Corp
    MCK US
    56,254
    10,889,6493.36
    Valeant Pharmaceuticals International I
    VRX US
    78,831
    9,803,4233.02
    Perrigo Co
    PRGO US
    36,014
    5,656,7191.74
    Mylan Inc/Pa
    MYL US
    105,494
    5,475,1391.69
    Zoetis Inc
    ZTS US
    136,490
    4,489,1561.38
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    35,486
    2,460,5990.76
    Hospira Inc
    HSP US
    40,598
    2,103,7880.65
    Salix Pharmaceuticals Ltd
    SLXP US
    11,864
    1,569,1330.48
    Questcor Pharmaceuticals Inc
    QCOR US
    15,012
    1,455,1130.45
    Other/Cash
    -605,925-0.19
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.